Formulation and In vitro Evaluation of Oral Fast Dissolving Tablets of A Novel Antidepressant Drug by Using Camphor As A Subliming Agent
Abstract
Abstract
The purpose of the present investigation is to formulate fast dissolving tablets of Venlafaxine HCl, a novel antidepressant by direct compression method using camphor as subliming agent in the three different concentrations of 2%, 5% and 10%. Croscarmellose, tulsion-414 and sodium starch glycolate were used as superdisintegrants in two different concentrations of 5% and 10%. The drug-excipients compatability was ruled out through FTIR studies. A total of six formulations were prepared with different concentrations of camphor and superdisintegrants. The prepared tablets were evaluated for thickness, hardness, friability, weight variation, drug content and in vitro dispersion time, wetting time and in vitro drug release. All the evaluation parameters were found to be within the limits of IP specifications. The disintegration time was found to be linearly decreases with the increase in the amount of superdisintegrant and camphor whereas the dissolution rate linearly increases. Among all the six formulations the tablets formulated with sodium starch glycolate with camphor were shown highest percentage of drug release within 10 minutes. It was concluded that oral fast dissolving tablets of Venlafaxine HCl can be successfully formulated by direct compression with camphor as subliming agent.
Keywords: Venlafaxine HCl, camphor, superdisintegrants, sublimation
Cite this Article
Sandeep SD, Narayana CR, Nayak P et al. Formulation and In vitro evaluation of oral fast dissolving tablets of a novel antidepressant drug by using camphor as a subliming agent. Research & Reviews: A Journal of Drug Design and Discovery. 2015; 2(3): 12–18p.
Downloads
Published
Issue
Section
License
Copyright Transfer and Declaration Form (Please compile this form, sign and send by e-mail and post)
Journal Title:
Title of the Paper:
Corresponding Author’s Information: Name: Address:
E-mail:
Contact Number: I
t is herein agreed that: The copyright to the above-listed unpublished and original article is transferred to STM Journals. This copyright transfer covers the exclusive right to reproduce and distribute the contribution, including reprints, translations, photographic reproductions, microform, electronic form (offline, online), or any other reproductions of similar nature. I/We declare that above manuscript is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere. I/ We warrant(s) that his/her/their contribution is original, except for such excerpts from copyrighted works as may be included with the permission of the copyright holder and author thereof, that it contains no libelous statements, and does not infringe on any copyright, trademark, patent, statutory right, or propriety right of others. I/We will not publish his/her/their above said contribution anywhere else without the prior written permission of the publisher unless it has been changed substantially.I/We also agree to the authorship of the article in the following order:Author(s) Name Signature(s)1. ________________2. ________________3. ________________4. ________________The author(s) agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal (comments if any to the editor can be added below).
